Adia Nutrition Inc. Opens First Satellite Location in Tinton Falls, NJ, Partnering with Keep Glowing Medical Spa and Dr. Michael Ellis
Adia Nutrition Inc. (OTC Pink: ADIA) has announced the opening of its first satellite location in Tinton Falls, New Jersey, through a strategic shared space agreement with Keep Glowing Medical Spa and Dr. Michael Ellis. The facility will operate under Adia Med, offering FDA-compliant regenerative treatments including AdiaVita and AdiaLink.
The location will provide stem cell therapies targeting inflammation, autoimmune disorders, and musculoskeletal issues. AdiaVita contains 100 million viable cells and 3 trillion exosomes per unit, while AdiaLink offers 3.5 trillion exosomes per unit. These products meet Section 361 of the Public Health Service Act standards.
This expansion follows the launch of Adia's flagship clinic in Winter Park, Florida, in January 2025. The partnership model reduces overhead costs while accessing an established patient base, serving as a template for future nationwide expansion in the $15.1 billion global stem cell market.
Adia Nutrition Inc. (OTC Pink: ADIA) ha annunciato l'apertura della sua prima sede satellite a Tinton Falls, New Jersey, attraverso un accordo strategico di condivisione dello spazio con Keep Glowing Medical Spa e il Dr. Michael Ellis. La struttura opererà sotto il nome di Adia Med, offrendo trattamenti rigenerativi conformi alla FDA, tra cui AdiaVita e AdiaLink.
La sede fornirà terapie con cellule staminali mirate a infiammazioni, disturbi autoimmuni e problemi muscoloscheletrici. AdiaVita contiene 100 milioni di cellule vitali e 3 trilioni di esosomi per unità, mentre AdiaLink offre 3,5 trilioni di esosomi per unità. Questi prodotti soddisfano gli standard della Sezione 361 del Public Health Service Act.
Questa espansione segue il lancio della clinica principale di Adia a Winter Park, Florida, nel gennaio 2025. Il modello di partnership riduce i costi generali consentendo di accedere a una base di pazienti consolidata, fungendo da modello per una futura espansione a livello nazionale nel mercato globale delle cellule staminali da 15,1 miliardi di dollari.
Adia Nutrition Inc. (OTC Pink: ADIA) ha anunciado la apertura de su primera ubicación satélite en Tinton Falls, Nueva Jersey, a través de un acuerdo estratégico de espacio compartido con Keep Glowing Medical Spa y el Dr. Michael Ellis. La instalación operará bajo Adia Med, ofreciendo tratamientos regenerativos cumplidores con la FDA, incluyendo AdiaVita y AdiaLink.
La ubicación proporcionará terapias con células madre dirigidas a la inflamación, trastornos autoinmunes y problemas musculoesqueléticos. AdiaVita contiene 100 millones de células viables y 3 billones de exosomas por unidad, mientras que AdiaLink ofrece 3.5 billones de exosomas por unidad. Estos productos cumplen con los estándares de la Sección 361 de la Ley de Servicios de Salud Pública.
Esta expansión sigue al lanzamiento de la clínica insignia de Adia en Winter Park, Florida, en enero de 2025. El modelo de asociación reduce los costos generales mientras accede a una base de pacientes establecida, sirviendo como plantilla para una futura expansión a nivel nacional en el mercado global de células madre de 15.1 mil millones de dólares.
Adia Nutrition Inc. (OTC Pink: ADIA)는 뉴저지주 틴턴 폴스에 첫 번째 위성 지점을 개설했다고 발표했습니다. 이는 Keep Glowing Medical Spa 및 Michael Ellis 박사와의 전략적 공유 공간 계약을 통해 이루어졌습니다. 이 시설은 Adia Med로 운영되며, FDA 규정을 준수하는 재생 치료를 제공할 예정입니다. 여기에는 AdiaVita 및 AdiaLink가 포함됩니다.
이 위치는 염증, 자가 면역 질환 및 근골격계 문제를 목표로 하는 줄기세포 치료를 제공합니다. AdiaVita는 단위당 1억 개의 생존 세포와 3조 개의 엑소좀을 포함하고 있으며, AdiaLink는 단위당 3.5조 개의 엑소좀을 제공합니다. 이러한 제품은 공공 건강 서비스 법의 361조 기준을 충족합니다.
이번 확장은 2025년 1월 플로리다주 윈터 파크에 Adia의 플래그십 클리닉이 개설된 이후 이루어진 것입니다. 파트너십 모델은 고정비용을 줄이는 동시에 기존 환자 기반에 접근할 수 있게 하여, 151억 달러 규모의 글로벌 줄기세포 시장에서 향후 전국적 확장을 위한 템플릿 역할을 합니다.
Adia Nutrition Inc. (OTC Pink: ADIA) a annoncé l'ouverture de son premier emplacement satellite à Tinton Falls, New Jersey, grâce à un accord stratégique de partage d'espace avec Keep Glowing Medical Spa et le Dr Michael Ellis. L'établissement fonctionnera sous le nom d'Adia Med, offrant des traitements régénératifs conformes à la FDA, y compris AdiaVita et AdiaLink.
Le site proposera des thérapies par cellules souches ciblant l'inflammation, les troubles auto-immuns et les problèmes musculo-squelettiques. AdiaVita contient 100 millions de cellules viables et 3 billions d'exosomes par unité, tandis qu'AdiaLink offre 3,5 billions d'exosomes par unité. Ces produits respectent les normes de la section 361 de la loi sur les services de santé publique.
Cette expansion fait suite au lancement de la clinique phare d'Adia à Winter Park, en Floride, en janvier 2025. Le modèle de partenariat réduit les coûts fixes tout en accédant à une base de patients établie, servant de modèle pour une future expansion nationale sur le marché mondial des cellules souches de 15,1 milliards de dollars.
Adia Nutrition Inc. (OTC Pink: ADIA) hat die Eröffnung seiner ersten Satellitenstandorte in Tinton Falls, New Jersey bekannt gegeben, durch eine strategische Vereinbarung über gemeinsam genutzte Räumlichkeiten mit Keep Glowing Medical Spa und Dr. Michael Ellis. Die Einrichtung wird unter Adia Med betrieben und bietet FDA-konforme regenerative Behandlungen an, darunter AdiaVita und AdiaLink.
Der Standort wird Stammzelltherapien anbieten, die auf Entzündungen, Autoimmunerkrankungen und muskuloskeletale Probleme abzielen. AdiaVita enthält 100 Millionen lebensfähige Zellen und 3 Billionen Exosomen pro Einheit, während AdiaLink 3,5 Billionen Exosomen pro Einheit bietet. Diese Produkte erfüllen die Standards der Section 361 des Public Health Service Act.
Diese Expansion folgt der Eröffnung der Flagship-Klinik von Adia in Winter Park, Florida, im Januar 2025. Das Partnerschaftsmodell senkt die Gemeinkosten, während es den Zugang zu einer etablierten Patientenbasis ermöglicht und als Vorlage für zukünftige landesweite Expansionen im globalen Markt für Stammzellen im Wert von 15,1 Milliarden Dollar dient.
- Strategic expansion into new market through cost-effective shared space model
- Access to established patient base through partnership with existing medical spa
- Offering FDA-compliant stem cell treatments in $15.1B market
- Scalable business model for nationwide expansion
- Dependent on third-party facility and practitioner for operations
- to single satellite location currently
Winter Park, Florida--(Newsfile Corp. - March 27, 2025) - Adia Nutrition Inc. (OTC Pink: ADIA), a leader in regenerative medicine and healthcare innovation, is excited to announce the opening of its first satellite location in Tinton Falls, New Jersey. This expansion is made possible through a strategic shared space agreement with Keep Glowing Medical Spa and renowned physician Dr. Michael Ellis, blending cutting-edge stem cell therapies with an established wellness hub.
Located within Keep Glowing Medical Spa, the new satellite site will operate under Adia Nutrition's medical division, Adia Med, offering FDA-compliant regenerative treatments such as AdiaVita (umbilical cord stem cells with 100 million viable cells and 3 trillion exosomes per unit) and AdiaLink (3.5 trillion exosomes per unit). These therapies, produced in partnership with an FDA-approved laboratory, meet Section 361 of the Public Health Service Act standards for minimal manipulation and homologous use, targeting conditions like inflammation, autoimmune disorders, and musculoskeletal issues.
https://keepglowingmedicalspa.com/
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10520/246027_keep_glow_website.jpg
"We're proud to collaborate with Keep Glowing Medical Spa and Dr. Michael Ellis to bring our regenerative solutions to Tinton Falls," said Larry Powalisz, CEO of Adia Nutrition Inc. "This shared space partnership taps into Keep Glowing Medical Spa's top-tier facility and Dr. Mike Ellis's exceptional expertise, letting us bring transformative care to you in a cost-effective, community-centered way. It's a seamless blend of innovation and a personal approach that puts patients first."
Dr. Michael Ellis, a respected figure in integrative medicine, will oversee clinical operations at the Tinton Falls location, ensuring patients receive personalized, high-quality care. Keep Glowing Medical Spa's established reputation for advanced aesthetic and wellness services complements Adia Med's mission, creating a seamless integration of regenerative therapies into their offerings. This partnership marks the first step in Adia Nutrition's plan to expand through similar collaborations nationwide, following the successful launch of its flagship clinic in Winter Park, Florida, in January 2025.
Dr. Michael Ellis
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10520/246027_dr__michael_ellis.jpg
The Tinton Falls satellite will provide patients with access to Adia Med's ethically sourced, lab-verified stem cell products without the need for international travel. By sharing space, Adia Nutrition reduces overhead while tapping into an existing patient base, setting a scalable model for future growth in the
For appointments or inquiries, contact Keep Glowing Medical Spa at 848-217-2662 or Adia Med at ceo@adiamed.com / 321-788-0850. Investors and media can learn more about this milestone in Adia Nutrition's journey to redefine healthcare.
For questions, inquiries or further information, please contact Larry Powalisz at ceo@adiamed.com or 321-788-0850.
About ADIA Nutrition Inc.:
Adia Nutrition Inc. is a publicly traded company (OTC Pink: ADIA) dedicated to revolutionizing healthcare and supplementation. With a focus on innovation and quality, the company has established two key divisions: a supplement division providing premium, organic supplements, and a medical division establishing Clinics that specialize in leading-edge stem cell therapies, most significantly Umbilical Cord Stem Cells (UCB-SC) and Autologous Hematopoietic Stem Cell Transplantation (aHSCT) treatments. Through these divisions, Adia Nutrition Inc. is committed to empowering individuals to live their best lives by addressing both nutritional needs and groundbreaking medical treatments.
Website: www.adianutrition.com
Website: www.adiamed.com
Website: www.adialabs.com
Website: www.biolete.com
Website: www.cementfactory.co
Twitter (X): @ADIA_Nutrition
Safe Harbor: This Press Release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a few uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission and OTC Markets, Inc. OTC Disclosure and News Service. The company undertakes no obligation to publicly update or revise any forward-looking statements, because of new information, future events or otherwise.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/246027
FAQ
What treatments does Adia Nutrition (ADIA) offer at its new Tinton Falls location?
How is Adia Nutrition (ADIA) expanding its presence through the Tinton Falls facility?
When did Adia Nutrition (ADIA) open its flagship clinic and where?
What is the market potential for Adia Nutrition's (ADIA) stem cell treatments?
